These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38137445)

  • 1. Oncostatin M's Involvement in the Pathogenesis of Chronic Rhinosinusitis: Focus on Type 1 and 2 Inflammation.
    Ishikawa C; Takeno S; Okamoto Y; Kawasumi T; Kakimoto T; Takemoto K; Nishida M; Ishino T; Hamamoto T; Ueda T; Tanaka A
    Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncostatin M acting via OSMR, augments the actions of IL-1 and TNF in synovial fibroblasts.
    Le Goff B; Singbrant S; Tonkin BA; Martin TJ; Romas E; Sims NA; Walsh NC
    Cytokine; 2014 Aug; 68(2):101-9. PubMed ID: 24767864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncostatin M promotes epithelial barrier dysfunction in patients with eosinophilic chronic rhinosinusitis with nasal polyps.
    Wang BF; Wang YY; Lin H; Yi YL
    Tissue Barriers; 2024 Sep; ():2399235. PubMed ID: 39225375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease.
    Pothoven KL; Norton JE; Hulse KE; Suh LA; Carter RG; Rocci E; Harris KE; Shintani-Smith S; Conley DB; Chandra RK; Liu MC; Kato A; Gonsalves N; Grammer LC; Peters AT; Kern RC; Bryce PJ; Tan BK; Schleimer RP
    J Allergy Clin Immunol; 2015 Sep; 136(3):737-746.e4. PubMed ID: 25840724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Alteration and Differential Expression of the Bitter Taste Receptor T2R38 in Human Paranasal Sinus in Patients with Chronic Rhinosinusitis.
    Takemoto K; Lomude LS; Takeno S; Kawasumi T; Okamoto Y; Hamamoto T; Ishino T; Ando Y; Ishikawa C; Ueda T
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-Expression and Localization of Angiotensin-Converting Enzyme-2 (ACE2) and the Transmembrane Serine Protease 2 (TMPRSS2) in Paranasal Ciliated Epithelium of Patients with Chronic Rhinosinusitis.
    Kawasumi T; Takeno S; Ishino T; Ueda T; Hamamoto T; Takemoto K; Horibe Y; Takashi O
    Am J Rhinol Allergy; 2022 May; 36(3):313-322. PubMed ID: 34989246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The AB loop and D-helix in binding site III of human Oncostatin M (OSM) are required for OSM receptor activation.
    Adrian-Segarra JM; Schindler N; Gajawada P; Lörchner H; Braun T; Pöling J
    J Biol Chem; 2018 May; 293(18):7017-7029. PubMed ID: 29511087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncostatin M receptor, positively regulated by SP1, promotes gastric cancer growth and metastasis upon treatment with Oncostatin M.
    Yu Z; Li Z; Wang C; Pan T; Chang X; Wang X; Zhou Q; Wu X; Li J; Zhang J; Liu B; Zhu Z; Su L
    Gastric Cancer; 2019 Sep; 22(5):955-966. PubMed ID: 30778797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncostatin M Induces a Pro-inflammatory Phenotype in Intestinal Subepithelial Myofibroblasts.
    Kokkotis G; Filidou E; Tarapatzi G; Spathakis M; Kandilogiannakis L; Dovrolis N; Arvanitidis K; Drygiannakis I; Valatas V; Vradelis S; Manolopoulos VG; Paspaliaris V; Kolios G; Bamias G
    Inflamm Bowel Dis; 2024 May; ():. PubMed ID: 38717842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of a splice variant of oncostatin M receptor beta in human esophageal squamous carcinoma.
    Kausar T; Sharma R; Hasan MR; Saraya A; Chattopadhyay TK; Gupta SD; Ralhan R
    Cell Oncol (Dordr); 2011 Jun; 34(3):177-87. PubMed ID: 21394648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased exhaled nitric oxide and its oxidation metabolism in eosinophilic chronic rhinosinusitis.
    Takeno S; Taruya T; Ueda T; Noda N; Hirakawa K
    Auris Nasus Larynx; 2013 Oct; 40(5):458-64. PubMed ID: 23489830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-5 and IL-6 are increased in the frontal recess of eosinophilic chronic rhinosinusitis patients.
    Kubota K; Takeno S; Taruya T; Sasaki A; Ishino T; Hirakawa K
    J Otolaryngol Head Neck Surg; 2017 May; 46(1):36. PubMed ID: 28464955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the CD40L/Oncostatin M/Oncostatin M receptor axis as an antiviral and immunostimulatory system disrupted in chronic HCV infection.
    Larrea E; Echeverria I; Riezu-Boj JI; Aldabe R; Guembe L; Sola I; Civeira MP; Sarobe P; Prieto J
    J Hepatol; 2014 Mar; 60(3):482-9. PubMed ID: 24418171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The AB loop of oncostatin M (OSM) determines species-specific signaling in humans and mice.
    Adrian-Segarra JM; Sreenivasan K; Gajawada P; Lörchner H; Braun T; Pöling J
    J Biol Chem; 2018 Dec; 293(52):20181-20199. PubMed ID: 30373773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-oncostatin M antibody inhibits the pro-malignant effects of oncostatin M receptor overexpression in squamous cell carcinoma.
    Kucia-Tran JA; Tulkki V; Scarpini CG; Smith S; Wallberg M; Paez-Ribes M; Araujo AM; Botthoff J; Feeney M; Hughes K; Caffarel MM; Coleman N
    J Pathol; 2018 Mar; 244(3):283-295. PubMed ID: 29205362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The IL-37-Mex3B-Toll-like receptor 3 axis in epithelial cells in patients with eosinophilic chronic rhinosinusitis with nasal polyps.
    Liu JX; Liao B; Yu QH; Wang H; Liu YB; Guo CL; Wang ZC; Li ZY; Wang ZZ; Ruan JW; Pan L; Yao Y; Chen CL; Wang H; Liang Y; Zhen G; Liu Z
    J Allergy Clin Immunol; 2020 Jan; 145(1):160-172. PubMed ID: 31330219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of Oncostatin M Signaling in Adipocytes Induces Insulin Resistance and Adipose Tissue Inflammation in Vivo.
    Elks CM; Zhao P; Grant RW; Hang H; Bailey JL; Burk DH; McNulty MA; Mynatt RL; Stephens JM
    J Biol Chem; 2016 Aug; 291(33):17066-76. PubMed ID: 27325693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation.
    Boniface K; Diveu C; Morel F; Pedretti N; Froger J; Ravon E; Garcia M; Venereau E; Preisser L; Guignouard E; Guillet G; Dagregorio G; Pène J; Moles JP; Yssel H; Chevalier S; Bernard FX; Gascan H; Lecron JC
    J Immunol; 2007 Apr; 178(7):4615-22. PubMed ID: 17372020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncostatin M regulates SOCS3 mRNA stability via the MEK-ERK1/2-pathway independent of p38(MAPK)/MK2.
    Ehlting C; Böhmer O; Hahnel MJ; Thomas M; Zanger UM; Gaestel M; Knoefel WT; Schulte Am Esch J; Häussinger D; Bode JG
    Cell Signal; 2015 Mar; 27(3):555-67. PubMed ID: 25562430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncostatin M triggers brain inflammation by compromising blood-brain barrier integrity.
    Hermans D; Houben E; Baeten P; Slaets H; Janssens K; Hoeks C; Hosseinkhani B; Duran G; Bormans S; Gowing E; Hoornaert C; Beckers L; Fung WK; Schroten H; Ishikawa H; Fraussen J; Thoelen R; de Vries HE; Kooij G; Zandee S; Prat A; Hellings N; Broux B
    Acta Neuropathol; 2022 Aug; 144(2):259-281. PubMed ID: 35666306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.